Literature DB >> 7568549

Normalization of the auditory P50 gating deficit of schizophrenic patients after non-REM but not REM sleep.

J M Griffith1, R Freedman.   

Abstract

Diminished suppression of the P50 response to repeated auditory stimuli is one example of a deficit in elementary sensory processing in schizophrenia. Normal subjects suppress the response to the second of two paired auditory stimuli. Although normal suppression is occasionally observed in schizophrenic patients, it generally disappears with subsequent testing. We have previously reported that slow wave sleep (SWS) transiently normalized suppression in schizophrenic patients and that the degree of suppression was positively correlated with the depth of SWS attained. We hypothesized that schizophrenic patients may have a defect that causes a neuronal mechanism to fail after brief use and that its activity can be restored by a transient period of inactivity. The present study examined whether this effect of sleep in schizophrenic patients is specific to SWS or is due to nonspecific factors involved in any period of unconsciousness. After baseline recordings, 10 schizophrenic subjects were allowed a period of sleep until they attained rapid-eye-movement (REM) sleep. They were awakened at the end of the REM period, and postsleep recordings were obtained. REM-stage sleep failed to normalize suppression in any of the schizophrenic subjects. P50 suppression was subsequently assessed after a period of non-REM (NREM) sleep. Subjects who reached stage-2 sleep did demonstrate a transient correction in auditory gating. These results replicate our previous findings and suggest that the sleep effect is specific to NREM sleep. A desensitized nicotinic receptor that is resensitized during cholinergic inactivity in NREM sleep is one possible mechanism for this effect.

Entities:  

Mesh:

Year:  1995        PMID: 7568549     DOI: 10.1016/0165-1781(95)02516-y

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring.

Authors:  M Camille Hoffman; Sharon K Hunter; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman
Journal:  Psychol Med       Date:  2019-07-31       Impact factor: 7.723

2.  Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development.

Authors:  Robert Freedman; Sharon K Hunter; Amanda J Law; Brandie D Wagner; Angelo D'Alessandro; Uwe Christians; Kathleen Noonan; Anna Wyrwa; M Camille Hoffman
Journal:  J Pediatr       Date:  2019-03-14       Impact factor: 4.406

3.  The effects of increased serotonergic activity on human sensory gating and its neural generators.

Authors:  Kristian S Jensen; Bob Oranje; Malene Wienberg; Birte Y Glenthøj
Journal:  Psychopharmacology (Berl)       Date:  2007-11-14       Impact factor: 4.530

4.  DMXB, an alpha7 nicotinic agonist, normalizes auditory gating in isolation-reared rats.

Authors:  Heidi C O'Neill; Kate Rieger; William R Kem; Karen E Stevens
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

5.  Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development.

Authors:  Sharon K Hunter; M Camille Hoffman; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman; Amanda J Law
Journal:  Psychol Med       Date:  2019-12-02       Impact factor: 7.723

6.  Prenatal choline, cannabis, and infection, and their association with offspring development of attention and social problems through 4 years of age.

Authors:  Sharon K Hunter; M Camille Hoffman; Angelo D'Alessandro; Anna Wyrwa; Kathleen Noonan; Steven H Zeisel; Amanda J Law; Robert Freedman
Journal:  Psychol Med       Date:  2021-01-25       Impact factor: 10.592

7.  Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia.

Authors:  Nikolaj Bak; Egill Rostrup; Henrik B W Larsson; Birte Y Glenthøj; Bob Oranje
Journal:  Hum Brain Mapp       Date:  2013-12-04       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.